Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001948800 | SCV002214856 | uncertain significance | Severe combined immunodeficiency due to DNA-PKcs deficiency | 2021-03-12 | criteria provided, single submitter | clinical testing | Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals with PRKDC-related conditions. This variant is present in population databases (rs751033972, ExAC 0.002%). This sequence change replaces aspartic acid with glycine at codon 1027 of the PRKDC protein (p.Asp1027Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. |
Ambry Genetics | RCV004043004 | SCV003964514 | uncertain significance | not specified | 2023-03-21 | criteria provided, single submitter | clinical testing | The c.3080A>G (p.D1027G) alteration is located in exon 27 (coding exon 27) of the PRKDC gene. This alteration results from a A to G substitution at nucleotide position 3080, causing the aspartic acid (D) at amino acid position 1027 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |